Connor, Clark & Lunn Investment Management (CC&L)’s STAAR Surgical STAA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-91,800	Closed	-$1.62M	–	1678
2025 Q1	$1.62M	Buy	91,800 +26,364	+40%	+$529K	0.01%	788
2024 Q4	$1.59M	Buy	65,436 +35,422	+118%	+$1.01M	0.01%	798
2024 Q3	$1.12M	Buy	30,014 +22,925	+323%	+$855K	0.01%	849
2024 Q2	$338K	Buy	+7,089	New	+$311K	﹤0.01%	1154
2014 Q2	–	Sell	-11,635	Closed	-$241K	–	625
2014 Q1	$241K	Buy	+11,635	New	+$187K	﹤0.01%	597

Other funds holding STAA

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return

Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s STAA Position: Q2 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of STAAR Surgical (STAA) in Q2 2025, closing a stake of 91,800 shares — an estimated $1.62M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in STAA in Q1 2014 and held it in 5 quarters. The position peaked at $1.62M in Q1 2025. 170 funds tracked by Wall St. Rank hold STAA as of Q2 2025.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining STAAR Surgical position as of Q2 2025 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 91,800 STAAR Surgical shares in Q2 2025, an estimated $1.62M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in STAAR Surgical in Q1 2014 and held it in 5 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s STAAR Surgical position peaked at $1.62M in Q1 2025.
170 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2025, filed 7 Aug 2025.